메뉴 건너뛰기




Volumn 7, Issue 3, 2006, Pages 277-278

How to ENHANCE our knowledge of activated protein C during pediatric sepsis trials: Pediatric versus adult trials

Author keywords

Activated protein C; Children; Intracranial bleeding; Sepsis; Therapy

Indexed keywords

DROTRECOGIN;

EID: 33646856388     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000219048.44785.F6     Document Type: Editorial
Times cited : (2)

References (10)
  • 1
    • 0035826096 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human activated protein C for severe sepsis
    • Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
    • (2001) N Engl J Med , vol.344 , pp. 699-709
    • Bernard, G.R.1    Vincent, J.L.2    Laterre, P.F.3
  • 2
    • 0038128677 scopus 로고    scopus 로고
    • Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study
    • de Kleijn ED, de Groot R, Hack CE, et al: Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31:1839-1847
    • (2003) Crit Care Med , vol.31 , pp. 1839-1847
    • De Kleijn, E.D.1    De Groot, R.2    Hack, C.E.3
  • 3
    • 19444374261 scopus 로고    scopus 로고
    • Pediatric sepsis definitions: Past, present and future
    • Brilli RJ, Goldstein B: Pediatric sepsis definitions: Past, present and future. Pediatr Crit Care Med 2005; 6(Suppl):S6-S8
    • (2005) Pediatr Crit Care Med , vol.6 , Issue.SUPPL.
    • Brilli, R.J.1    Goldstein, B.2
  • 4
    • 19444364187 scopus 로고    scopus 로고
    • Scope and epidemiology of pediatric sepsis
    • Watson RS, Carcillo JA: Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6(Suppl):S3-S5
    • (2005) Pediatr Crit Care Med , vol.6 , Issue.SUPPL.
    • Watson, R.S.1    Carcillo, J.A.2
  • 6
    • 0035512794 scopus 로고    scopus 로고
    • Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery
    • Booy R, Habibi P, Nadel S, et al: Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85:386-390
    • (2001) Arch Dis Child , vol.85 , pp. 386-390
    • Booy, R.1    Habibi, P.2    Nadel, S.3
  • 7
    • 0030442743 scopus 로고    scopus 로고
    • Age-related differences in outcome and severity of DIC in children with septic shock and purpura
    • Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, et al: Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromt Haemost 1996; 76:932-938
    • (1996) Thromt Haemost , vol.76 , pp. 932-938
    • Hazelzet, J.A.1    Risseeuw-Appel, I.M.2    Kornelisse, R.F.3
  • 8
    • 33646864520 scopus 로고    scopus 로고
    • Enhance: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis
    • Goldstein B, Nadel S, Peters M, et al: Enhance: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis. Pediatr Crit Care Med 2006; 7:200-211
    • (2006) Pediatr Crit Care Med , vol.7 , pp. 200-211
    • Goldstein, B.1    Nadel, S.2    Peters, M.3
  • 9
    • 9144264948 scopus 로고    scopus 로고
    • Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis
    • Barton P, Dalil AC, Nadel S, et al: Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics 2004; 113:7-17
    • (2004) Pediatrics , vol.113 , pp. 7-17
    • Barton, P.1    Dalil, A.C.2    Nadel, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.